Angell Shieh, Ph.D.
Affiliations: | 2008 | Biomedical Sciences | University of California, San Francisco, San Francisco, CA |
Area:
Molecular Biology, Cell BiologyGoogle:
"Angell Shieh"Parents
Sign in to add mentor| Scott Kogan | grad student | 2008 | UCSF | |
| (Interrogating the roles of specific downstream effector pathways in the pathogenesis of hematopoietic malignancies initiated by oncogenic K-RasG12D.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Shieh A, Ward AF, Donlan KL, et al. (2013) Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo. Blood. 121: 4884-93 |
| Jones L, Wei G, Sevcikova S, et al. (2010) Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia. The Journal of Experimental Medicine. 207: 2581-94 |
| Ward AF, Shieh A, Harding-Theobald ER, et al. (2010) Akt Activation Is Important In KRAS-Mediated Multistep Leukemogenesis Blood. 116: 4200-4200 |
| Jones L, Sevcikova S, Phan V, et al. (2008) Myc Drives Chromosomal Gain in Acute Myeloid Leukemia Blood. 112: 792-792 |
| Li Q, Haigis K, McDaniel A, et al. (2007) Expressing N-RasG12D from the Endogenous Promoter Induces Myeloproliferative Disease (MPD) and Cooperates with Retroviral Insertional Mutagenesis (RIM) To Generate Acute Myeloid Leukemia (AML). Blood. 110: 1616-1616 |